Fluidigm (FLDM) has a profit margin of 128.99%, above the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for FLDM is 128.99% as of September 2026. That compares with -99.55% in the prior-year period — up 229.6% year over year. That is above the Healthcare sector average of 17.63%. Investors often review this figure alongside Fluidigm's historical trend and sector peers before judging valuation or financial health.
Over the past year, FLDM's profit margin moved from -99.55% to 128.99% — a 229.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fluidigm's valuation or profitability profile.
Against Healthcare companies, FLDM currently prints 128.99% for profit margin, while the sector average sits near 17.63%. That is roughly 631.7% above the sector mean. Large gaps often invite a closer look at Fluidigm's growth, margins, and balance sheet.
Profit Margin shows how effectively Fluidigm converts resources into returns. At 128.99%, FLDM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -99.55% in the prior-year period — up 229.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting FLDM's profit margin (128.99%), review year-over-year change from -99.55%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.